The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-41
SponsorReproductive Medicine Associates of New Jersey

About this trial

This study aims to assess the effect of age of the male partner and the reproductive ability of sperm prepared via sperm selection devices (Zymot) compared to routine embryologist selected sperm after density gradient centrifugation (DGC) preparation for intracytoplasmic sperm injection (ICSI) in patients undergoing in vitro fertilization treatment (IVF) of their infertility.

Eligibility criteria

Qualifiers

Undergoing first IVF cycle

Electing single embryo transfer

Electing PGT-A of their embryos

Female partners age <42 years old at start of VOR cycle, but >18 years old.

Disqualifiers

Contraindication to IVF

Clinical indication for preimplantation genetic testing (i.e., screening for single gene disorder, chromosomal translocation, or any other disorders requiring a more detailed embryo genetic analysis)

Male partner with azoospermia or oligozoospermia (<500,000 total motile spermatozoa on the most recent semen analysis within one year of enrollment)

Planned for previously cryopreserved sperm to be used for ICSI

Trial design

Treatments tested in this trial

  • Microfluidic sperm separation device
  • Density grade centrifugation

Treatment groups

100 Participants
are divided into 2 treatment groups